MyFinsight
Home
Blog
About
Back
Income Statement
Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO)
source: myfinsight.com
Net gain and
comprehensive gain
-$6,373K
(59.78%↑ Y/Y)
Loss from operations
-$3,491K
(75.70%↑ Y/Y)
Total other income
(expense), net
-$2,882K
(-94.99%↓ Y/Y)
Total revenue
$18,692K
(131.22%↑ Y/Y)
Other income
(expense), net
$1,058K
(174.09%↑ Y/Y)
Total operating
expenses
$22,183K
(-1.19%↓ Y/Y)
Change in fair value of
common stock warrant...
$3,940K
(7780.00%↑ Y/Y)
Research and development
$14,559K
(-5.03%↓ Y/Y)
General and
administrative
$7,624K
(7.08%↑ Y/Y)
Back